Increased S100A4 expression is associated with increased Src and FAK activation in human pancreatic tumor tissues, and S100A4-deficient tumors show remarkably decreased FAK and Src activation in vivo in a pancreatic cancer mouse model (Fig. 4E and Supplementary Fig. S2). This evidence concerns the gene S100A4 and pancreatic neoplasm.